Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05948683
Other study ID # IRB23-0219
Secondary ID 5R01DA002812-35
Status Recruiting
Phase Early Phase 1
First received
Last updated
Start date July 21, 2023
Est. completion date June 2024

Study information

Verified date August 2023
Source University of Chicago
Contact Hanna Molla
Phone 7737023560
Email hmolla@uchicago.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, the aim is to test the hypothesis that MDMA produces greater prosocial effects when administered in the presence of a familiar, compared to an unfamiliar, person


Description:

MDMA has shown promise as an adjunct to psychotherapy in the treatment of PTSD and other disorders. When used clinically with psychotherapy, the drug is believed to interact with the interpersonal components of the psychotherapy, especially the patient-therapist interaction. Indeed, patients and therapists usually form a strong alliance during several preparatory sessions, even before a drug is administered. Experts believe that the patient's familiarity and trust of the therapist is critical to the success of the intervention. Whereas therapeutic alliance is critical to the success of any psychotherapy, it may be especially important when psychoactive drugs are part of the treatment. The importance of this trust-building component preceding drug-assisted therapy has not been investigated. There are mechanistic reasons to expect that MDMA will be more effective when a patient interacts with a familiar and trusted other person, compared to a stranger. MDMA is thought to exert its "prosocial" effects by increasing the social bonding hormone, oxytocin, and this hormone may contribute to its therapeutic effects. However, there is evidence that oxytocin increases feelings of connectedness specifically with familiar "in-group" members, and that it may not produce affiliative effects with individuals who are unfamiliar, or perceived to be outside their groups. Thus, the pro-social effects of oxytocin may depend on the degree of familiarity and closeness of the interacting partner. As noted above, during preparatory sessions in drug-assisted psychotherapy the patient forms a bond with a therapists before the drug is administered, which may serve to increase the 'in-group' effect of the drug, and thus maximize the therapeutic potential of the MDMA. Controlled laboratory studies (without psychotherapy) show that MDMA produces prosocial effects on measures of mood and socio-emotional function. However, most of these studies are conducted in isolated individuals, or with study partners who have no prior relationship with the participant. In this proposed study the study team will investigate whether the prosocial effects of MDMA are greater when interacting with a partner to whom the participant feels close and more connected, compared to a partner who is unfamiliar. To establish familiarity in one of the study groups the study team will use a procedure designed to establish feelings of closeness and connectedness between two strangers. In this procedure, two same-sex partners, who are initially strangers, engage in a 45 min conversation with one of two sets of topics provided by the experimenter. In one condition the topics remain superficial ("small talk" condition) and in the other, they become progressively deeper ("deep talk" condition) over the 45 mins. The study team and others have shown that the deep talk condition produces feelings of connection between the partners, and participants report feeling understood and liking their partners. In the present study, the investigator will use this procedure to establish familiarity between conversation partners. The investigator aims to test the hypothesis that MDMA produces greater prosocial effects when administered in the presence of a familiar, compared to an unfamiliar, person. Participants will participate in four sessions, in which they receive MDMA (100 mg) or a placebo and then engage in a 15-min conversation with a familiar or unfamiliar person.


Recruitment information / eligibility

Status Recruiting
Enrollment 34
Est. completion date June 2024
Est. primary completion date June 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - used MDMA or psychedelic between 1-40 - high school diploma or equivalent - BMI between 19 and 30 - verbal fluency in English Exclusion Criteria: - History of adverse effects with MDMA - High blood pressure - Any medical condition requiring regular medication - Individuals with a current (within the last year) DSM-IV Axis 1 diagnosis - Women who are pregnant or trying to become pregnant.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
MDMA
The stimulant MDMA
Placebo
Dextrose

Locations

Country Name City State
United States University of Chicago Chicago Illinois

Sponsors (3)

Lead Sponsor Collaborator
University of Chicago National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Natural Language Processing using large language model Differences in speech content across all conditions during 15 minute test conversation, occurring 1.5 hours after drug administration
Primary Facial expression analysis using HUMEAI software Changes in emotional expressions during conversations during 15 minute test conversation, occurring 1.5 hours after drug administration
Secondary Oxytocin Changes in oxytocin levels across all conditions 120 minutes post drug administration
Secondary Self-reported feelings of connection using Likert scale conversation questionnaires ratings of connectedness Collected at the end of the session, 240 minutes post-drug administration
Secondary Affective touch Ratings of pleasantness, intensity and want more touch (1-7) after differing velocities of touch Post-drug, 2 hours post-drug administration
See also
  Status Clinical Trial Phase
Completed NCT03824353 - Social Intelligence Training in Midlife Phase 2
Not yet recruiting NCT05558527 - The Social Regulation of Threat-related Vigilance and Arousal N/A
Completed NCT02592265 - Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden N/A
Completed NCT04426370 - The Effects of Social Role Participation on Life Quality
Completed NCT04164628 - Evaluation of Quality of Life in Women N/A
Recruiting NCT05503745 - MICBT for Non-underweight Adults With Eating Disorders N/A
Completed NCT03643003 - Music Therapy for Persons With Dementia N/A
Completed NCT05185453 - Strengthening Adolescent-Adult Networks to Reduce Youth Violence N/A
Recruiting NCT05345405 - Clinical Trial of a Supporter-Targeted Intervention to Improve Outcomes in Recent Sexual Assault Survivors N/A
Completed NCT05316766 - Multi-user Touch Surfaces for Promoting Social Participation and Self-efficacy in Upper-limb Stroke Rehabilitation N/A
Recruiting NCT04514133 - Testing the Causal Effects of a Civic Engagement Intervention on Health and Wellbeing Among Youth (I-ACTED) N/A
Recruiting NCT05907252 - The Effectiveness of Supervised Group-based Walking Program Among Older Adults N/A
Completed NCT03974282 - Brain Function and Decision-Making N/A
Completed NCT06135623 - Long-Term Impact of COVID-19 Restrictions on Physical Activity and Social Interactions in Young Adults
Active, not recruiting NCT04298047 - A 3-month Cycle of Weekly Montreal Museum of Fine Arts Tours N/A
Completed NCT02217748 - Name Generator Order Effects in Social Networks N/A
Completed NCT04665401 - Personalizing Interventions Using Real-World Interactions N/A
Completed NCT03557723 - Effect of Art Museum Activity Program for the Elderly on Health: A Pilot Observational Study
Completed NCT03679715 - A-Health RCT: Effects of Participatory Art-based Activity on Health of Older Community Dwellers N/A
Completed NCT04662593 - Koa Family Study--A Community-Based Intervention to Improve Health and Well-Being N/A